Clinical safety profile of sotalol in patients with arrhythmias
- 1 January 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (2) , 74-81
- https://doi.org/10.1016/0002-9149(90)90207-h
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- SotalolDrugs, 1987
- Sotalol: A beta blocker with unique antiarrhythmic propertiesAmerican Heart Journal, 1987
- Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: Criteria of efficacy in patients with sustained ventricular tachyarrhythmiaJournal of the American College of Cardiology, 1987
- Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.Circulation, 1985
- Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.Circulation, 1984
- Determinants of Survival in Patients with Ventricular TachyarrhythmiasNew England Journal of Medicine, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970
- Temporal Relation Between Long-Lasting Aftercontractions and Action Potentials in Cat Papillary MusclesScience, 1968